Lipoprotein(a) as a blood marker for large artery atherosclerosis stroke etiology: validation in a prospective cohort from a swiss stroke center.

Publication

Lipoprotein(a) as a blood marker for large artery atherosclerosis stroke etiology: validation in a prospective cohort from a swiss stroke center.

Journal Paper/Review - Apr 2, 2024

Rudin Salome, Kriemler Lilian, Dittrich Tolga, Zietz Annaelle, Schweizer Juliane, Arnold Markus, Peters Nils, Barinka Filip, Jung Simon, Arnold Marcel, Fischer Urs, Rentsch Katharina M, Christ-Crain Mirjam, Katan Mira, De Marchis Gian Marco

Citation

Rudin S, Kriemler L, Dittrich T, Zietz A, Schweizer J, Arnold M, Peters N, Barinka F, Jung S, Arnold M, Fischer U, Rentsch K, Christ-Crain M, Katan M, De Marchis G. Lipoprotein(a) as a blood marker for large artery atherosclerosis stroke etiology: validation in a prospective cohort from a swiss stroke center. Swiss Med Wkly 2024; 154:3633.

Type

Journal Paper/Review (English)

Journal

Swiss Med Wkly 2024; 154

Publication Date

Apr 2, 2024

Issn Electronic

1424-3997

Pages

3633

Brief description/objective

Lipoprotein (a) [Lp(a)] serum levels are highly genetically determined and promote atherogenesis. High Lp(a) levels are associated with increased cardiovascular morbidity. Serum Lp(a) levels have recently been associated with large artery atherosclerosis (LAA) stroke. We aimed to externally validate this association in an independent cohort.